News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
844,336 Results
Type
Article (86361)
Company Profile (702)
Press Release (757273)
Multimedia
Podcasts (125)
Webinars (13)
Section
Business (232615)
Career Advice (4125)
Deals (39711)
Drug Delivery (129)
Drug Development (90957)
Employer Resources (198)
FDA (18085)
Job Trends (17323)
News (396333)
Policy (39721)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (11)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (6)
2025 BioForest Digital (13)
2025 Lone Star Bio Digital (16)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (2)
Academia (2999)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (90)
Alliances (56780)
ALS (96)
Alzheimer's disease (1489)
Antibody-drug conjugate (ADC) (143)
Approvals (18048)
Artificial intelligence (307)
Autoimmune disease (26)
Automation (15)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (21)
Biosimilars (116)
Biotechnology (481)
Bladder cancer (67)
Brain cancer (31)
Breast cancer (282)
Cancer (2234)
Cardiovascular disease (193)
Career advice (3530)
Career pathing (33)
CAR-T (164)
Cell therapy (464)
Cervical cancer (21)
Clinical research (73212)
Collaboration (859)
Compensation (516)
Complete response letters (30)
COVID-19 (2859)
CRISPR (45)
C-suite (243)
Cystic fibrosis (107)
Data (2095)
Decentralized trials (2)
Denatured (44)
Depression (52)
Diabetes (282)
Diagnostics (6899)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (148)
Drug pricing (123)
Drug shortages (33)
Duchenne muscular dystrophy (96)
Earnings (96301)
Editorial (41)
Employer branding (25)
Employer resources (167)
Events (129390)
Executive appointments (718)
FDA (19313)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (772)
Gene editing (114)
Generative AI (34)
Gene therapy (334)
GLP-1 (837)
Government (5140)
Grass and pollen (5)
Guidances (50)
Healthcare (20883)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (136)
Indications (27)
Infectious disease (3016)
Inflammatory bowel disease (148)
Inflation Reduction Act (11)
Influenza (56)
Intellectual property (94)
Interviews (812)
IPO (17801)
IRA (51)
Job creations (5185)
Job search strategy (2861)
Kidney cancer (10)
Labor market (39)
Layoffs (545)
Leadership (21)
Legal (10109)
Liver cancer (78)
Lung cancer (323)
Lymphoma (144)
Machine learning (5)
Management (65)
Manufacturing (322)
MASH (70)
Medical device (14596)
Medtech (14601)
Mergers & acquisitions (22410)
Metabolic disorders (754)
Multiple sclerosis (80)
NASH (23)
Neurodegenerative disease (107)
Neuropsychiatric disorders (31)
Neuroscience (2057)
NextGen: Class of 2025 (7682)
Non-profit (5077)
Northern California (2574)
Now hiring (38)
Obesity (409)
Opinion (272)
Ovarian cancer (76)
Pain (92)
Pancreatic cancer (82)
Parkinson's disease (156)
Partnered (24)
Patents (234)
Patient recruitment (103)
Peanut (51)
People (65155)
Pharmaceutical (143)
Pharmacy benefit managers (21)
Phase I (22586)
Phase II (31779)
Phase III (23963)
Pipeline (1152)
Policy (155)
Postmarket research (3552)
Preclinical (10143)
Press Release (72)
Prostate cancer (102)
Psychedelics (38)
Radiopharmaceuticals (268)
Rare diseases (418)
Real estate (7391)
Recruiting (75)
Regulatory (26695)
Reports (57)
Research institute (2657)
Resumes & cover letters (649)
Rett syndrome (4)
RNA editing (4)
RSV (48)
Schizophrenia (77)
Series A (136)
Series B (86)
Service/supplier (30)
Sickle cell disease (58)
Southern California (2241)
Special edition (18)
Spinal muscular atrophy (166)
Sponsored (33)
Startups (4287)
State (2)
Stomach cancer (16)
Supply chain (71)
Tariffs (24)
The Weekly (79)
United States (23362)
Vaccines (782)
Venture capitalists (39)
Weight loss (297)
Women's health (39)
Worklife (19)
Date
Today (65)
Last 7 days (489)
Last 30 days (2634)
Last 365 days (36110)
2025 (9875)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1271)
Alabama (59)
Alaska (7)
Arizona (265)
Arkansas (14)
Asia (50019)
Australia (8819)
California (6001)
Canada (1965)
China (523)
Colorado (266)
Connecticut (290)
Delaware (143)
Europe (114675)
Florida (880)
Georgia (212)
Hawaii (1)
Idaho (64)
Illinois (598)
India (29)
Indiana (321)
Iowa (10)
Japan (152)
Kansas (109)
Kentucky (27)
Louisiana (13)
Maine (70)
Maryland (921)
Massachusetts (4644)
Michigan (241)
Minnesota (407)
Mississippi (2)
Missouri (88)
Montana (31)
Nebraska (26)
Nevada (60)
New Hampshire (69)
New Jersey (1723)
New Mexico (31)
New York (1708)
North Carolina (1091)
North Dakota (8)
Northern California (2574)
Ohio (209)
Oklahoma (15)
Oregon (47)
Pennsylvania (1332)
Puerto Rico (12)
Rhode Island (32)
South America (1651)
South Carolina (20)
South Dakota (1)
Southern California (2241)
Tennessee (99)
Texas (908)
Utah (181)
Virginia (160)
Washington D.C. (67)
Washington State (578)
West Virginia (3)
Wisconsin (65)
There are 844,336 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avistone Announces Preclinical Results for ANS03, a Novel Type II ROS1/NTRK Inhibitor in Overcoming Clinically Relevant ROS1/NTRK Resistance Mutations at AACR Annual Meeting 2025
April 15, 2025
·
2 min read
Press Releases
Emulate Applauds FDA’s Roadmap to Reduce Animal Testing and Embrace Organ-Chip Technologies
April 15, 2025
·
3 min read
Job Trends
Bonus Episode: Q1 2025 Job Market Update
In this bonus episode,
BioSpace’s
vice president of marketing
Chantal Dresner
and careers editor
Angela Gabriel
take a look at Q1 job market performance, layoffs and administration decisions impacting the workforce.
April 15, 2025
·
1 min read
·
Angela Gabriel
Layoff Tracker
Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives
2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
April 15, 2025
·
179 min read
·
BioSpace Editorial Staff
Tariffs
J&J CEO Duato Urges Tax Fix, Not Tariffs To Drive US Pharma Manufacturing
In the company’s first-quarter earnings call Tuesday, J&J CEO Joaquin Duato said there’s a better way to encourage drug manufacturing in the U.S. than President Donald Trump’s threatened pharma tariffs.
April 15, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
Psyence BioMed Announces USD$500,000 Follow-On Investment in PsyLabs and Global Ibogaine Supply Agreement
April 15, 2025
·
8 min read
Collaboration
Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M
Merck has not disclosed which of its peptide therapies it plans to develop oral formulations for.
April 15, 2025
·
2 min read
·
Tristan Manalac
Earnings
J&J Beats Q1 Analyst Estimates Thanks To Tremfya, Carvykti, While Stelara Fades
J&J opened Q1 2025 pharma earnings Tuesday, reporting sales of $21.9 billion and diluted earnings per share of $4.54. The medicines unit provided $13.9 billion while the medtech unit generated the remaining $8 billion.
April 15, 2025
·
2 min read
·
Annalee Armstrong
Cardiovascular disease
BMS’ Camzyos Fails To Show New Cardiomyopathy Benefit in Phase III
According to analysts at BMO Capital Markets, non-obstructive hypertrophic cardiomyopathy would have meant a $1.3 billion label expansion opportunity for Camzyos.
April 15, 2025
·
2 min read
·
Tristan Manalac
Collaboration
Boehringer Ingelheim Boosts I&I Portfolio With $357M in Biobucks for Cue
At the heart of the licensing deal is CUE-501, a bispecific molecule that can selectively deplete B cells to address autoimmune and inflammatory conditions.
April 15, 2025
·
2 min read
·
Tristan Manalac
1 of 84,434
Next
